UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...

This story is part of the KXAN Data Hub, where numbers help tell the whole story. We’ve created several data-driven stories and databases on topics including weather and climate, politics, education, ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Erika Rasure is globally-recognized as a leading ...

The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 50% of Likely U.S. Voters approve of President Trump’s job performance. Forty-nine (49%) disapprove. The latest figures ...

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 51% of Likely U.S. Voters approve of President Trump’s job performance. Forty-eight (48%) disapprove. The latest figures ...